Why the study?
Does a transvenous pacemaker system reduce early mortality compared to thoracotomy for epicardial/intramyocardial electrodes in patients receiving their first pacemaker implant?
Does a transvenous pacemaker system reduce early mortality compared to thoracotomy for epicardial/intramyocardial electrodes in patients receiving their first pacemaker implant?
A 1972 survey of pacemaker implantations in Australia and New Zealand demonstrated that transvenous pacemaker systems were associated with significantly lower early mortality compared to thoracotomy approaches.
Supports transvenous preference in first implants; leaves open causal effects and relevance to contemporary randomized practice.
During 1972, cardiac pacemaking experience in Australia and New Zealand was surveyed. Twenty cardiovascular units in 10 major cities supplied information concerning implantation of 676 generators. There were 341 first implants and 335 replacements. A transvenous pacemaker system was used for pacemaking in 305 (89%) of the 341 patients receiving their first implants. The early mortality in the group receiving a transvenous system was significantly less than the mortality amongst the 32 patients who had a thoracotomy for the establishment of either intramyocardial or epicardial electrodes. There was a growing tendency to implant ventricular synchronous and ventricular inhibited generators in preference to the asynchronous types of generators. The generators were supplied by a wide range of manufacturers which included the Australian manufacturer Telectronics, Elema of Sweden, Medtronics from the United States and Devices from the United Kingdom. As a result of the survey a simple recording form, designed for computer analysis, has been developed and is recommended for progressive record keeping.
No takes yet. Share an insight, caveat, or question.
Sloman et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: